Research Article
Aflatoxin-Related Immune Dysfunction in Health and in Human Immunodeficiency Virus Disease
Table 1
Demographic and clinical
characteristics of HIV positive and HIV negative study participants.
| | Characteristic | HIV positive | HIV negative | | High AF-ALB | Low AF-ALB | High AF-ALB | Low AF-ALB |
| | Total number of participants | 58 | 58 | 40 | 40 |
| | Age (mean ± SD years) | 38.289.65 | 38.229.30 | 39.5018.25 | 42.0816.86 |
| | Gender number (%) | | | | | | Male | 24 (41.4) | 17 (29.3) | 23 (57.5) | 22 (55) | | Female | 34 (58.6) | 41 (70.7) | 17 (42.5) | 18 (45) |
| | Viral load (mean ± SD copies/ml) | 85049±230696 | 70260±193163 | 0 | 0 | | CD4 count (mean ± SD cells/L) | 316±266 | 298±230 | 1001±209 | 1197±614 |
| | CDC classification number (%) | | | | | | A | 10 (17.3) | 7 (12.1) | | | | B | 25 (43.1) | 27 (46.5) | | | | C | 23 (39.7) | 24 (41.4) | | |
| | AF-ALB (mean ± SD pmol/mg albumin) | 1.440.56 | 0.590.24 | 1.310.36 | 0.700.14 |
|
|
Aflatoxin B1
albumin adducts (AF-ALB)—Mean ± SD = pmoL/mg albumin; median = 0.91 pmoL/mg albumin;
range = 0–3.48 pmoL/mg albumin.
“High AF-ALB”
participants were 0.91 pmoL/mg
albumin; “low AF-ALB” participants were 0.91 pmoL/mg albumin.
SD = standard deviation.
|
